Evaluation of new markers for minimal residual disease monitoring in B‐cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000–000

Publisher： John Wiley & Sons Inc

E-ISSN： 1552-4957|94|1|100-111

ISSN： 1552-4949

Source： Cytometry. Part B: Clinical Cytometry, Vol.94, Iss.1, 2018-01, pp. : 100-111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Detection of minimal residual disease in B lymphoblastic leukemia using viSNE

By  

Cytometry. Part B: Clinical Cytometry, Vol. 88, Iss. 5, 2015-09 ,pp. : 294-304

John Wiley & Sons Inc

Access to resources Recommend Favorite

A novel flow cytometric assay for detection of residual disease in patients with B‐lymphoblastic leukemia/lymphoma post anti‐CD19 therapy

By  

Cytometry. Part B: Clinical Cytometry, Vol. 94, Iss. 1, 2018-01 ,pp. : 112-120

John Wiley & Sons Inc

Access to resources Recommend Favorite

Implementation of a simplified flow cytometric assays for minimal residual disease monitoring in childhood acute lymphoblastic leukemia

By  

Cytometry. Part B: Clinical Cytometry, Vol. 94, Iss. 1, 2018-01 ,pp. : 94-99

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human interferon-alpha increases the cytotoxic effect of CD56+cord blood-derived cytokine-induced killer cells on human B-acute lymphoblastic leukemia cell lines

By Durrieu Ludovic   Gregoire-Gauthier Joëlle   Dieng Mame Massar   Fontaine François   le Deist Françoise   Haddad Elie  

Cytotherapy, Vol. 14, Iss. 10, 2012-11 ,pp. : 1245-1257

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Fine Needle Aspiration Biopsy of Precursor B-Cell Lymphoblastic Lymphoma Presenting as a Sacral Mass

By  

Acta Cytologica, Vol. 48, Iss. 2, 2011-02 ,pp. : 239-242

Karger

Access to resources Recommend Favorite